ArticlePathogens (Basel, Switzerland)2024
The
Abstract read
In one paragraph
Article in Pathogens (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- Beyond probiotics: Lacticaseibacillus rhamnosus as a multi-target antagonist of Pseudomonas aeruginosa infections.Folia microbiologica · 2026Review
- Prevalence and genotypic distribution of virulence factor genes and antibiotic susceptibility profiles in clinicalMicrobiology spectrum · 2026Article
- Correlation of type 3 secretion system genes with antimicrobial resistance inJournal of Taibah University Medical Sciences · 2026Article
- Antibiofilm activity of Limosilactobacillus fermentum SH2 and Lactococcus lactis extracts against strains of methicillin-resistant Staphylococcus aureus, Staphylococcus hominis SH7, and Pseudomonas aeruginosa.Molecular biology reports · 2026Article
- WGS reveals high-risk clones of Pseudomonas aeruginosa harbouring extensive antimicrobial and predicted anti-phage defense systems recovered from diabetic foot ulcer patients in Egypt.BMC microbiology · 2026Article
- Genomic and Phenotypic Insights into Carbapenem-ResistantMicroorganisms · 2026Article
- Comprehensive characterization of virulence factors in Pseudomonas aeruginosa clinical isolates from Bushehr, Iran: High proportion of exoU-positive isolates.BMC microbiology · 2026Article
- Molecular characteristics of chromosome-mediated colistin resistance in carbapenem-resistant Pseudomonas aeruginosa isolates from a tertiary hospital in China.BMC microbiology · 2026Article
- Integrated FTIR and Whole-Genome Sequencing Reveal Scale-Dependent Genotype-Phenotype Relationships in Multidrug-ResistantPathogens (Basel, Switzerland) · 2026Article
- Genomic variants distinguish Pseudomonas aeruginosa from cystic fibrosis sputum and bloodstream infection.BMC infectious diseases · 2026Article
- Comparative phenotypic and genotypic analysis of distinctFrontiers in cellular and infection microbiology · 2026Article
- A conserved virulence backbone and heterogeneous type III secretion effector profiles in historical canine otitis-associatedFrontiers in veterinary science · 2026Article
- Molecular epidemiological association between antimicrobial resistance characteristics and type III secretion system in carbapenem-resistantFrontiers in cellular and infection microbiology · 2026Article
- High-resolution long-read sequencing maps genomic Island-associated gene duplication in South African carbapenem non-susceptibleFrontiers in microbiology · 2026Article
- Unveiling the molecular epidemiology of Pseudomonas aeruginosa in lung infections among cystic fibrosis patients in the Brazilian Amazon.BMC microbiology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Carolina G Nolasco-RomeroLaboratorio de Investigación en Microbiología y Resistencia Antimicrobiana, Hospital Infantil de México Federico Gómez, Mexico City 06720, Mexico.ORCID 0000-0001-5680-0646
Francisco-Javier Prado-GalbarroDepartamento de Investigación, Hospital Infantil de México Federico Gómez, Mexico City 06720, Mexico.ORCID 0000-0002-1474-5228
Rodolfo Norberto Jimenez-JuarezDepartamento de Infectología, Hospital Infantil de México Federico Gómez, Mexico City 06720, Mexico.
Uriel Gomez-RamirezLaboratorio de Investigación en Microbiología y Resistencia Antimicrobiana, Hospital Infantil de México Federico Gómez, Mexico City 06720, Mexico.ORCID 0000-0003-2223-226X
Juan Carlos Cancino-DíazLaboratorio de inmunomicrobiología, Departamento de Microbiología, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Mexico City 11350, Mexico.ORCID 0000-0002-3708-7010
Beatriz López-MarcelianoLaboratorio de Investigación en Microbiología y Resistencia Antimicrobiana, Hospital Infantil de México Federico Gómez, Mexico City 06720, Mexico.ORCID 0000-0002-9064-4226
Magali Reyes ApodacaUnidad de Investigación y Diagnóstico en Nefrología y Metabolismo Mineral Óseo, Hospital Infantil de México Federico Gómez, Mexico City 06720, Mexico.ORCID 0000-0001-6211-7843
Mónica Anahí Aguayo-RomeroDepartamento de Infectología, Hospital Infantil de México Federico Gómez, Mexico City 06720, Mexico.
Gerardo E RodeaPosgrado en Ciencias Quimicobiológicas, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Mexico City 11350, Mexico.
Lilia Pichardo-VillalonLaboratorio Clínico, Hospital Infantil de México Federico Gómez, Mexico City 067209, Mexico.
Israel Parra-OrtegaLaboratorio Clínico, Hospital Infantil de México Federico Gómez, Mexico City 067209, Mexico.ORCID 0000-0002-7195-1749
Fortino Solórzano SantosLaboratorio de Investigación en Enfermedades Infecciosas, Hospital Infantil de México Federico Gómez, Mexico City 06720, Mexico.
Mónica Moreno-GalvánDepartamento de Hemato-Oncología, Hospital Infantil de México Federico Gómez, Mexico City 06720, Mexico.
Norma Velázquez-GuadarramaLaboratorio de Investigación en Microbiología y Resistencia Antimicrobiana, Hospital Infantil de México Federico Gómez, Mexico City 06720, Mexico.ORCID 0000-0002-3620-7260
Funding
Hospital Infantil de México Federico Gómez HIM/2017/042. SSA 1742.
Abstract
The poor prognosis of infections associated with multidrug-resistant
Indexed as
ADP Ribose TransferasesBacterial ProteinsBacterial ToxinsCystic FibrosisDrug Resistance, Multiple, BacterialPseudomonas aeruginosaPseudomonas InfectionsType III Secretion SystemsVirulence FactorsAdolescentAnti-Bacterial AgentsChildChild, PreschoolFemaleGTPase-Activating ProteinsHumansADP Ribose TransferasesAnti-Bacterial AgentsBacterial ProteinsBacterial Toxinsexoenzyme SExoT protein, Pseudomonas aeruginosaGTPase-Activating Proteinspseudomonas exoprotein A protein, Pseudomonas aeruginosaType III Secretion SystemsVirulence Factorsdeathmultidrug resistancePseudomonas aeruginosatype 3 secretion system
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.